22 March 2024
ECO Animal Health Group plc
("ECO" or the "Company")
Share Awards to Executive Directors
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announced that on 21 March 2024, nominal cost conditional share options were granted under the Company's Long Term Incentive Plan (the "LTIP") over 176,652 ordinary shares in the Company (representing approximately 0.26 percent of the Company's issued share capital) to Executive Directors listed below.
| Name | Position | Number of Share Awards |
| David Hallas | Chief Executive Officer | 101,403 |
| Chris Wilks | Chief Financial Officer | 75,249 |
These awards under the LTIP are subject to performance conditions being met which have been set by the Company's Remuneration Committee and relate to Total Shareholder Return ("TSR") and Research and Development ("R&D") targets. Subject to the performance conditions being met, awards will vest after the end of a three year vesting period. Further details on the LTIP can be found in the Company's 2022 Annual Report.
-Ends-
For further information please contact:
| |
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com
PDMR Notification - ECO LTIP Nominal Cost Conditional Share Awards
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a. | Name | David Hallas
| ||||
| 2. | Reason for the notification | |||||
| a. | Position/status | Chief Executive Officer
| ||||
| b. | Initial notification /Amendment
| Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a. | Name | Eco Animal Health Group Plc | ||||
| b. | LEI | 2138009XN9DJ3YP70B55 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a. | Description of the Financial instrument, type of instrument Identification code | Options over ordinary shares of 5p each.
GB0032036807
| ||||
| b. | Nature of the transaction | Award of nominal cost conditional share awards under the Company's LTIP. | ||||
| c. | Price(s) and volume(s) |
| ||||
| d. | Aggregated information Aggregated volume Price |
n/a
| ||||
| e. | Date of the transaction | 21 March 2024 | ||||
| f. | Place of the transaction | Outside a trading venue.
| ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a. | Name | Chris Wilks
| ||||
| 2. | Reason for the notification | |||||
| a. | Position/status | Chief Financial Officer
| ||||
| b. | Initial notification /Amendment
| Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a. | Name | Eco Animal Health Group Plc | ||||
| b. | LEI | 2138009XN9DJ3YP70B55 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a. | Description of the Financial instrument, type of instrument Identification code | Options over ordinary shares of 5p each.
GB0032036807
| ||||
| b. | Nature of the transaction | Award of nominal cost conditional share awards under the Company's LTIP. | ||||
| c. | Price(s) and volume(s) |
| ||||
| d. | Aggregated information Aggregated volume Price |
n/a
| ||||
| e. | Date of the transaction | 21 March 2024 | ||||
| f. | Place of the transaction | Outside a trading venue.
| ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
